Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentino Conter

Showing results (31-40 of 131) with videos related to

Pageof 14
Sort By:
Cancer|June 4, 2008
Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP)Maurizio Arico, Ottavio Ziino, Maria Grazia Valsecchi, et al.
British Journal of Haematology|January 16, 2014
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?Adriana Balduzzi, Lucia Di Maio, Daniela Silvestri, et al.
Expert Review of Hematology|July 28, 2015
Infectious complications in children with acute lymphoblastic leukemia treated in low-middle-income countriesMiguela A Caniza, Carla Odio, Sheena Mukkada, et al.
Pediatric Blood & Cancer|May 18, 2011
Autologous purified peripheral blood stem cell transplantation compare to chemotherapy in childhood acute lymphoblastic leukemia after low-risk relapseAdriana Balduzzi, Stefania Galimberti, Maria G Valsecchi, et al.
Haematologica|December 11, 2013
Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia"Chiara Palmi, Tobia Lana, Daniela Silvestri, et al.
Transplantation|August 14, 2015
Risk-adapted Treatment for Severe B-Lineage Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation in ChildrenEugenia Giraldi, Massimo Provenzi, Valentino Conter, et al.
Haematologica|April 16, 2013
What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?Chiara Palmi, Maria Grazia Valsecchi, Giulia Longinotti, et al.
Pharmacogenomics|December 7, 2017
DNA variants in DHFR gene and response to treatment in children with childhood B ALL: revisited in AIEOP-BFM protocolFrancesco Ceppi, Vincent Gagné, Laurance Douyon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhoodLara Mussolin, Marta Pillon, Valentino Conter, et al.
Transplantation and Cellular Therapy|January 23, 2023
A Hematopoietic Stem Cell Transplantation Startup in Iraqi Kurdistan: Results in Thalassemia Patients and Analysis of the MethodologyMarta Verna, Marta Canesi, Valentino Conter, et al.
Pageof 14

Showing results (31-40 of 131) with videos related to

Sort By:
Pageof 14
Cancer|June 4, 2008
Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP)Maurizio Arico, Ottavio Ziino, Maria Grazia Valsecchi, et al.
British Journal of Haematology|January 16, 2014
Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?Adriana Balduzzi, Lucia Di Maio, Daniela Silvestri, et al.
Expert Review of Hematology|July 28, 2015
Infectious complications in children with acute lymphoblastic leukemia treated in low-middle-income countriesMiguela A Caniza, Carla Odio, Sheena Mukkada, et al.
Pediatric Blood & Cancer|May 18, 2011
Autologous purified peripheral blood stem cell transplantation compare to chemotherapy in childhood acute lymphoblastic leukemia after low-risk relapseAdriana Balduzzi, Stefania Galimberti, Maria G Valsecchi, et al.
Haematologica|December 11, 2013
Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia"Chiara Palmi, Tobia Lana, Daniela Silvestri, et al.
Transplantation|August 14, 2015
Risk-adapted Treatment for Severe B-Lineage Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation in ChildrenEugenia Giraldi, Massimo Provenzi, Valentino Conter, et al.
Haematologica|April 16, 2013
What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?Chiara Palmi, Maria Grazia Valsecchi, Giulia Longinotti, et al.
Pharmacogenomics|December 7, 2017
DNA variants in DHFR gene and response to treatment in children with childhood B ALL: revisited in AIEOP-BFM protocolFrancesco Ceppi, Vincent Gagné, Laurance Douyon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhoodLara Mussolin, Marta Pillon, Valentino Conter, et al.
Transplantation and Cellular Therapy|January 23, 2023
A Hematopoietic Stem Cell Transplantation Startup in Iraqi Kurdistan: Results in Thalassemia Patients and Analysis of the MethodologyMarta Verna, Marta Canesi, Valentino Conter, et al.
Pageof 14